CGP 6.78% 6.3¢ consegna group limited

Just the most ridiculous study:1. Not published2. Compared...

  1. 46 Posts.
    Just the most ridiculous study:
    1. Not published
    2. Compared Breathe Assist sports to Breathe Assist Snoring models. Why would you do this? Better to compare to nothing or a competitor brand.
    3. "80% reduction in airflow resistance". Why would you look at this as an outcome?? Much better to look at something that is important and and end point for sports performance, e.g. time trial speed, time at xx% of max to fatigue, heart rate at xx% of max power etc.

    The next trial in Oct/Nov at ACU in Melbourne sounds more promising. However anyone who knows anything about Sports Medicine will throw this one out.
 
watchlist Created with Sketch. Add CGP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.